BusinessCardiologyTechnology

Coronary Stents Show Clinical and Economic Staying Power

1 Mins read

The worldwide market for coronary stents is estimated to be greater than $7 billion, with annual growth estimated at more than 5%. The largest factor in the growth of this market is found in the aging of populations in developed countries. This has resulted in a growth rate for PCI procedures of roughly 3%–5% overall. The advent of percutaneous coronary intervention with stenting revolutionized treatment protocols for patients with cardiovascular disease. The availability of stents gave cardiovascular surgeons the opportunity to treat more patients more effectively. The strongest area of growth is currently drug-eluting stents, which after their introduction, quickly overshadowed the growth in bare metal stents. However, after clinical trial results were released in 2006 showing that bare metal stents had outperformed drug-eluting stents (DESs), the market for DESs took a severe hit with many physicians backing away from the newer technology and choosing to implant bare metal stents instead. Combined with manufacturing issues, both Johnson & Johnson/Cordis and Boston Scientific (the only two competitors on the U.S. market) saw significant drops in sales by year-end. However, the market bottomed out in 2007, aided in part by more positive study results. Data presented at the European Society of Cardiology meeting showed that in a 35,000-patient Swedish registry, patients receiving DESs are not at a higher risk of dying or suffering a heart attack as compared to patients receiving bare metal stents. While DESs do present a small increased risk of late-stent thrombosis after the first year, this is offset by better outcomes in the early months after implantation. Although clinical data therefore buttressed the prior evidence that the longer term outcomes were positive, the market for DESs encountered a downward trend driven in part by lingering doubt among clinicians and healthcare systems about the relative efficacy and safety of DESs and in part by the economic climate that punished the higher premiums for DES versus bare metal stents. As the economy has subsequently stabilized, the downward pressure on prices and the strong clinical outcomes data have sustained DES markets, at least until better interventional options emerge, whether those are absorbable stents, drug eluting balloons or other options.


Excerpted from Report #C45, “Worldwide Market for Drug-Eluting, Bare and Other Coronary Stents, 2008-2017.

Avatar
183 posts

About author
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses. Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.
Articles
Related posts
Technology

How Healthcare Workers and Administrators Can Reduce Their Facility’s Carbon Footprint

3 Mins read
The environmental impact of modern-day culture has reached an unsustainable point. Individuals, governments, and corporations are all working to reduce their carbon…
Business

Building Your HGH Levels for Better Health and Stronger Muscles

7 Mins read
Over the years, people have tried countless methods to grow muscles and achieve their ultimate physical goals. Using different performance enhancers and…
Business

6 Critical Healthcare Marketing Tactics to Win Over New Patients

3 Mins read
Finding clients for a medical practice is not easy. It is even harder in 2020 than it was years ago. Changing customer…